SCHEMBL564633

SCHEMBL564633

Nc1cc(Cc2ccc(O)cc2)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.58
ESR2 Q92731 2/20 0.58
GAA P10253 3/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57
KMT2A Q03164 1/20 0.57
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
IDH1 O75874 1/20 0.48
ALDH1A1 P00352 3/20 0.47
GFER P55789 1/20 0.47
KEAP1 Q14145 1/20 0.44
ALOX15 P16050 3/20 0.43
HSD17B10 Q99714 2/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29412587 0.91 GAA (0.67) ESR1ESR2GAAKDM4EMEN1
SCHEMBL29860720 0.91 GAA (0.67) ESR1ESR2GAAKDM4EMEN1
SCHEMBL564615 0.91 GAA (0.67) ESR1ESR2GAAKDM4EMEN1
Hydrochloric Acid SCHEMBL21173959 0.89 GAA (0.64) ESR1ESR2GAAKDM4EMEN1
SCHEMBL565060 0.88 ALDH1A1 (0.58) ESR1ESR2GAAKDM4EMEN1
SCHEMBL29350695 0.86 IDH1 (0.68) ESR1ESR2GAAKDM4EMEN1
SCHEMBL564652 0.86 IDH1 (0.68) ESR1ESR2GAAKDM4EMEN1
SCHEMBL20132138 0.84 ALDH1A1 (0.61) ESR1ESR2GAAKDM4EMEN1
SCHEMBL564946 0.84 KDM4E (0.53) ESR1ESR2GAAKDM4EMEN1
SCHEMBL8514724 0.83 GAA (0.83) ESR1ESR2GAAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 US disclosed
EP-2098226-A1 AKAP-PKA interaction inhibitors for use in the treatment of heart diseases Forschungsverbund Berlin e.V. (DE) 2009-09-09 EP disclosed
EP-2098226-A1 AKAP-PKA interaction inhibitors for use in the treatment of heart diseases Forschungsverbund Berlin e.V. (DE) 2009-09-09 EP disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 ESR1 1065/4885ESR2 1253/4885GAA 3993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.